Other Equity

Equity

Eli Lilly Other Equity decreased by 29.0% to $22.00M in Q4 2025 compared to the prior quarter.

Analysis

StatementBalance Sheet Statement
SectionEquity
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2024
Last reportedQ4 2025

How to read this metric

Significant changes may indicate share buyback programs or unique accounting adjustments that warrant further investigation in the footnotes.

Detailed definition

A catch-all category for equity components that do not fit into standard classifications like retained earnings or commo...

Peer comparison

Varies by company; often contains treasury stock which is common for companies with active share repurchase programs.

Metric ID: other_equity

Historical Data

2 periods
 Q4 '24Q4 '25
Value$31.00M$22.00M
QoQ Change-29.0%
YoY Change-29.0%
Range$22.00M$31.00M
Avg YoY Growth-29.0%
Median YoY Growth-29.0%

Frequently Asked Questions

What is Eli Lilly's other equity?
Eli Lilly (LLY) reported other equity of $22.00M in Q4 2025.
What does other equity mean?
Miscellaneous equity items not classified in major equity categories.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.